Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 478-482

  Matera, Maria Gabriella ^a   Calzetta, Luigino ^b   Parascandolo, Vincenzo ^a   Curradi, Giacomo ^c   Rogliani, Paola ^c   Cazzola, Mario ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARBACHOL; HISTAMINE; PAPAVERINE;

ARTICLE; BRONCHODILATATION; BRONCHUS; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG INHIBITION; GUINEA PIG; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

BRONCHI; BRONCHIAL HYPERREACTIVITY; CARBACHOL; HISTAMINE; HUMANS; IMMUNIZATION, PASSIVE; MUSCLE CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; NICOTINIC AGONISTS; PAPAVERINE; VASODILATOR AGENTS;

EID: 71249112362     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.04.005     Document Type: Article

References (36)

1. Pandey K.N. Biology of natriuretic peptides and their receptors. Peptides 26 (2005) 901-932
2. Rose R.A., and Giles W.R. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 586 (2008) 353-366
3. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130 (1992) 229-239
4. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27 (2006) 47-72
5. Maack T. Receptors of atrial natriuretic factors. Annu Rev Physiol 54 (1992) 11-27
6. Matsukawa N., Grzesik W.J., Takahashi N., Pandey K.N., Pang S., Yamauchi M., et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A 96 (1999) 7403-7408
7. Bianchi C., Gutkowska J., Thibault G., Garcia R., Genest J., and Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry 82 (1985) 441-452
8. Ishii Y., Watanabe T., Watanabe M., Hasegawa S., and Uchiyama Y. Effects of atrial natriuretic peptide on type II alveolar epithelial cells of the rat lung. Autoradiographic and morphometric studies. J Anat 166 (1989) 85-95
9. Kawaguchi S., Uchida K., Ito T., Kozuka M., Shimonaka M., Mizuno T., et al. Immunohistochemical localization of atrial natriuretic peptide receptor in bovine kidney and lung. J Histochem Cytochem 37 (1989) 1739-1742
10. Fernandes L.B., Preuss J.M., and Goldie R.G. Epithelial modulation of the relaxant activity of atriopeptides in rat and guinea-pig tracheal smooth muscle. Eur J Pharmacol 212 (1992) 187-194
11. O'Donnell M., Garippa R., and Welton A.F. Relaxant activity of atriopeptins in isolated guinea pig airway and vascular smooth muscle. Peptides 6 (1985) 597-601
12. Ishii K., and Murad F. ANP relaxes bovine tracheal smooth muscle and increases cGMP. Am J Physiol 256 (1989) C495-C500
13. Angus R.M., Nally J.E., McCall R., Young L.C., McGrath J.C., and Thomson N.C. Modulation of the effect of atrial natriuretic peptide in human and bovine bronchi by phosphoramidon. Clin Sci 86 (1994) 291-295
14. Angus R.M., McCallum M.J., and Thomson N.C. Effect of inhaled atrial natriuretic peptide on methacholine induced bronchoconstriction in asthma. Clin Exp Allergy 24 (1994) 784-788
15. Angus R.M., McCallum M.J., Hulks G., and Thomson N.C. Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma. Am Rev Respir Dis 147 (1993) 1122-1125
16. Angus R.M., Millar E.A., Chalmers G.W., and Thomson N.C. Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction. Am J Respir Crit Care Med 151 (1995) 2003-2005
17. Mizuguchi M., Myo S., and Fujimura M. Bronchoprotective effects of atrial natriuretic peptide against propranolol-induced bronchoconstriction after allergic reaction in guinea pigs. Clin Exp Allergy 30 (2000) 439-444
18. Mcalpine L.G., Hulks G., and Thomson N.C. Effect of atrial natriuretic peptide given by intravenous infusion on bronchoconstriction induced by ultrasonically nebulized distilled water (fog). Am Rev Respir Dis 146 (1992) 912-915
19. Takagi K., and Araki N. Relaxant effects of brain natriuretic peptide on guinea-pig tracheal smooth muscle. Clin Exp Pharmacol Physiol 20 (1993) 239-243
20. Ohbayashi H., Suito H., and Takagi K. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. Eur J Pharmacol 346 (1998) 55-64
21. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
22. Watson N., Bodtke K., Coleman R.A., Dent G., Morton B.E., Rühlmann E., et al. Role of IgE in hyperresponsiveness induced by passive sensitization of human airways. Am J Respir Crit Care Med 155 (1997) 839-844
23. Robichaud A., Michoud M.C., Hamet P., and du Souich P. Plasma atrial natriuretic peptide during spontaneous bronchoconstriction in asthmatics. Peptides 16 (1995) 653-656
24. Ishii J., Nomura M., Ito M., Naruse H., Mori Y., Wang J.H., et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 301 (2000) 19-30
25. Leuchte H.H., Neurohr C., Baumgartner R., Holzapfel M., Giehrl W., Vogeser M., et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170 (2004) 360-365
26. Hulks G., Jardine A.G., Connell J.M., and Thomson N.C. Effect of atrial natriuretic factor on bronchomotor tone in the normal human airway. Clin Sci (Lond) 79 (1990) 51-55
27. Chanez P., Mann C., Bousquet J., Chabrier P.E., Godard P., Braquet P., et al. Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol 86 (1990) 321-324
28. Hulks G., and Thomson N.C. High dose inhaled atrial natriuretic peptide is a bronchodilator in asthmatic subjects. Eur Respir J 7 (1994) 1593-1597
29. Akerman M.J., Yaegashi M., Khiangte Z., Murugan A.T., Abe O., and Marmur J.D. Bronchodilator effect of infused B-type natriuretic peptide in asthma. Chest 130 (2006) 66-72
30. Candenas M.L., Naline E., Puybasset L., Devillier P., and Advenier C. Effect of atrial natriuretic peptide and on atriopeptins on the human isolated bronchus. Comparison with the reactivity of the guinea-pig isolated trachea. Pulm Pharmacol 4 (1991) 120-125
31. Labat C., Norel X., Benveniste J., and Brink C. Vasorelaxant effects of atrial peptide II on isolated human pulmonary muscle preparations. Eur J Pharmacol 150 (1988) 397-400
32. Hamad A.M., Range S., Holland E., and Knox A.J. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Am J Physiol 273 (1997) L807-L813
33. Rabe K.F. Mechanisms of immune sensitization of human bronchus. Am J Respir Crit Care Med 158 (1998) S161-S170
34. Persson C.G. Role of plasma exudation in asthmatic airways. Lancet 2 8516 (1986) 1126-1129
35. Passino C., Sironi A.M., Favilli B., Poletti R., Prontera C., Ripoli A., et al. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Int J Cardiol 104 (2005) 39-45
36. Mohapatra S.S. Role of natriuretic peptide signaling in modulating asthma and inflammation. Can J Physiol Pharmacol 85 (2007) 754-759